Acadia Pharmaceuticals (ACAD) Interest & Investment Income (2010 - 2013)
Acadia Pharmaceuticals' Interest & Investment Income was $41,000 in Q1 2013, up 215.4% from $13,000 a year earlier and up 355.6% from the prior quarter.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Interest & Investment Income (2010 - 2013) Analysis & Trends
On a trailing twelve-month basis, Acadia Pharmaceuticals' Interest & Investment Income was $65,000 through Mar 31, 2013, down 9.7% year-over-year; for FY2012, it came in at $37,000, down 57.5% from FY2011.
- Interest & Investment Income shows a three-year compound annual growth rate of -51.4% (FY2009 to FY2012).
- In earlier years, Interest & Investment Income was $87,000 in FY2011 (+93.3%), $45,000 in FY2010 (-86.1%) and $323,000 in FY2009.
- The Q1 2013 figure marks the highest quarterly Interest & Investment Income in data going back to Q2 2010.
- Compared with a year earlier, Interest & Investment Income was higher in four of the last eight quarters, with growth averaging 33.9%.
- The best year-over-year quarter for Interest & Investment Income over five years was Q2 2011 (growth of 250.0%); the worst was Q3 2012 (a decline of 70.6%).
- Per Business Quant data, ACAD's Interest & Investment Income in the three quarters before Q1 2013 was $9,000 (Q4 2012), $5,000 (Q3 2012) and $10,000 (Q2 2012).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | - |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | - |
| 10 | Acadia Pharmaceuticals | 3.40 Bn | -78.46 Mn | 279.64 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2013 | 41,000.00 |
| Dec 31, 2012 | 9,000.00 |
| Sep 30, 2012 | 5,000.00 |
| Jun 30, 2012 | 10,000.00 |
| Mar 31, 2012 | 13,000.00 |
| Dec 31, 2011 | 14,000.00 |
| Sep 30, 2011 | 17,000.00 |
| Jun 30, 2011 | 28,000.00 |
| Mar 31, 2011 | 28,000.00 |
| Dec 31, 2010 | 12,000.00 |
| Sep 30, 2010 | 15,000.00 |
| Jun 30, 2010 | 8,000.00 |
API Access
Acadia Pharmaceuticals Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();